VCN-01

DB18193InvestigationalGene Therapies

VCN-01 is an investigational, genetically modified human adenovirus encoding human PH20.

Mechanism: Pharmacologically active on Hyaluronan and Hyaluronidase PH-20
Curator reviewed
Code names: VCN-01

Resolves to

Compound

Targets

What you can answer from here — as of October 05, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with VCN-01, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.